We are here for you during the COVID-19 pandemic. Discover ways to protect yourself. Coronavirus & MesotheliomaWe are here for you during the COVID-19 pandemic. Discover ways to protect yourself.Explore Now


The Vanderbilt-Ingram Cancer Center is at the forefront of lung cancer and mesothelioma treatment, providing screenings, second opinions and individualized treatment for a patient’s cancer.

Specialists at the Vanderbilt-Ingram Cancer Center have experience diagnosing the disease, as well as providing second opinions, with a variety of tests like CT scans, MRIs and endoscopic ultrasounds. The center provides a variety of treatment options depending on the patient’s individual case, including advanced robotic surgery, minimally invasive surgery, immunotherapy, radiation and chemotherapy. Radiation is used as a treatment or as a palliative therapy to reduce symptoms and manage pain. The center offers targeted therapy, biologic therapy and clinical trials to patients as alternative treatment options, as well. They assess the cancer on an individual basis, using genetic testing to find the best treatment options.

Patient navigators are also available to patients to relieve them of the stress of scheduling appointments and collecting medical and financial records. Patients may access survivorship and support services as part of their care at the Vanderbilt-Ingram Cancer Center.


  • Chemotherapy
  • Radiation therapy
  • Surgery
  • Targeted therapy


  • CEO Cancer Gold Standard
  • National Cancer Institute (NCI) Comprehensive Care Center
  • National Cancer Institute (NCI) National Clinical Trials Network accreditation
  • National Comprehensive Cancer Network (NCCN) accreditation

Mesothelioma Clinical Trials at Vanderbilt-Ingram Cancer Center

The following clinical trials are in progress or actively recruiting participants at Vanderbilt-Ingram Cancer Center:

Collecting Tumor Samples From Patients With Gynecological Tumors

Conditions: Carcinoma, Carcinoma, Squamous Cell, Ovarian Neoplasms, Carcinoma, Ovarian Epithelial, Uterine Cervical Neoplasms, Neoplasms, Germ Cell and Embryonal, Mesothelioma, Fallopian Tube Neoplasms, Peritoneal Neoplasms, Rhabdomyosarcoma, Germinoma, Leiomyosarcoma, Vulvar Neoplasms, Vaginal Neoplasms, Cystadenocarcinoma, Trophoblastic Neoplasms, Gestational Trophoblastic Disease, Carcinoma, Small Cell, Small Cell Lung Carcinoma, Carcinoma, Adenosquamous, Cystadenocarcinoma, Serous, Brenner Tumor, Sarcoma, Endometrial Stromal, Rhabdomyosarcoma, Embryonal, Neoplasms

Last Updated: October 26, 2016

Status: Completed

A Safety and Tolerability Study of INCAGN02385 in Select Advanced Malignancies

Conditions: Carcinoma, Merkel Cell, Carcinoma, Lung Neoplasms, Melanoma, Small Cell Lung Carcinoma, Lymphoma, Large B-Cell, Diffuse, Endometrial Neoplasms, Mesothelioma, Triple Negative Breast Neoplasms, Squamous Cell Carcinoma of Head and Neck, Microsatellite Instability

Last Updated: October 22, 2019

Status: Recruiting

Arginase Inhibitor INCB001158 as a Single Agent and in Combination With Immune Checkpoint Therapy in Patients With Advanced/Metastatic Solid Tumors

Conditions: Carcinoma, Renal Cell, Mesothelioma

Last Updated: February 26, 2020

Status: Recruiting

Photo of Vanderbilt-Ingram Cancer Center

Get Help Contacting Vanderbilt-Ingram Cancer Center

    Privacy policy: All information is secure and will never be released



    Mesothelioma Treatment Guide

    Please fill in the form to request our FREE Mesothelioma Treatment Guide.
    It will be sent to you within 24 hours.

    Free Mesothelioma Treatment Guide

      Privacy policy: All information is secure and will never be released